The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and ...

The FTC believes that the PBMs participated in unjust competition and practices, incentivizing manufacturers to increase insulin list prices. “Express Scripts intends to vigorously defend itself to ...

in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the FTC published a ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

The FTC accuses major PBMs of inflating insulin prices, impacting patient costs and access to affordable medications. PBMs prioritize high-rebate drugs, contributing to high insulin prices and ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

and CVS Caremark – over alleged anti-competitive practices that have driven up insulin costs. The FTC is reported to be preparing its own lawsuit against the top companies in the sector ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...

The three firms—which the FTC says manages about 80% of prescriptions in the U.S.—have created a “perverse” drug rebate system that has “artificially inflated” insulin’s price ...